RecruitingNot ApplicableNCT06767332

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

Sponsor

Leiden University Medical Center

Enrollment

30 participants

Start Date

Nov 1, 2023

Study Type

INTERVENTIONAL

Conditions

Familial Melanoma Fear of Cancer Recurrence Eye Movement Desensitization and Reprocessing Psychological Intervention

Summary

High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether EMDR (Eye Movement Desensitization and Reprocessing) — a type of therapy commonly used for trauma — can help reduce the fear of cancer coming back in people who have been diagnosed with familial melanoma. Participants will be randomly assigned to receive EMDR therapy immediately or to wait and serve as a comparison group first. **You may be eligible if...** - You have been diagnosed with familial melanoma - You experience significant fear of cancer recurrence (scoring 16 or higher on the Fear of Cancer Recurrence Inventory short form) - You are 18 years or older - You speak sufficient Dutch to participate **You may NOT be eligible if...** - You do not speak Dutch well enough to engage in therapy - You are currently experiencing an acute psychiatric illness, psychosis, or active thoughts of suicide - You are taking anxiety medication (benzodiazepines) at a variable or unstable dose Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEReye movement desensitization and reprocessing (EMDR)

EMDR is a psychological intervention that has historically been applied to the treatment of Post-Traumatic Stress Disorder (PTSD), but has since then been shown to be effective for a variety of anxiety disorders (e.g. fear of illness and specific phobia) (Logie \& de Jongh, 2014) and somatic complaints such as post-operative pain, medically unexplained symptoms and seizure-related post-traumatic stress (Dautovic, de Roos, van Rood, Dommerholt, \& Rodenburg, 2016; van Rood \& de Roos, 2009; Maroufi, Zamani, Izadikhah, Marofi, \& O'Connor, 2016). With more than 25 randomized clinical trials, EMDR has been established as an evidence-based intervention for PTSD and PTSD symptomatology including physical symptoms and fear of future catastrophes (Balkom van et al., 2013).

Locations(2)

Leiden University Medical Center

Leiden, South Holland, Netherlands

Leiden University Medical Centre

Leiden, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06767332

Related Trials

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

NCT072346563 locations

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

NCT068176941 location

Study of Self-Help and Support Services for Student Mental Health in Tertiary Institutions

NCT066236821 location

Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Post-traumatic Symptoms.

NCT064693331 location

E-intervention on Subclinical Fear of Cancer Recurrence

NCT062070061 location